Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres

被引:67
作者
Ito, F
Makino, K
机构
[1] Sci Univ Tokyo, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan
[2] Sci Univ Tokyo, Ctr Drug Delivery Res, Noda, Chiba 2788510, Japan
[3] Sci Univ Tokyo, Inst Colloid & Interface Sci, Noda, Chiba 2788510, Japan
关键词
membrane emulsification technique; SPG membrane; pore size; monodisperse microspheres; rifampicin; PLGA;
D O I
10.1016/j.colsurfb.2004.08.016
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Monodispersed rifampicin (RFP)-loaded poly(lactide-co-glycolide) (PLGA) microspheres were prepared by a solvent evaporation method. In order to control the sizes of the microspheres, a membrane emulsification technique using Shirasu porous glass (SPG) membranes was applied. RFP/PLGA microspheres with the average diameters of 1.3, 2.2, 5.2, and 9.0 mum were obtained. They were relatively monodisperse and the values of the coefficient of variation (CV) for the size distributions of the microspheres were in the range between 7.0 and 16.0%. The loading efficiency of RFP was in the range between 50.3 and 67.4% independent of the microsphere size. The release ratio of RFP from RFP/PLGA microspheres was measured in pH 7.4 PBS at 37 degreesC. From RFP/PLGA microspheres with average diameters of 1.3 and 2.2 mum, almost 60% of RFP loaded in the microspheres was released in the initial day and the release was terminated almost within 10 days. On the other hand, from those with average diameters of 5.2, and 9.0 mum, the release of RFP was observed even 20 days after the release started. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 14 条
[1]   Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages [J].
Barrow, ELW ;
Winchester, GA ;
Staas, JK ;
Quenelle, DC ;
Barrow, WW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2682-2689
[2]   The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices [J].
Jain, RA .
BIOMATERIALS, 2000, 21 (23) :2475-2490
[3]   Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin [J].
Makino, K ;
Nakajima, T ;
Shikamura, M ;
Ito, F ;
Ando, S ;
Kochi, C ;
Inagawa, H ;
Soma, GI ;
Terada, H .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2004, 36 (01) :35-42
[4]   AN APPROACH TO PREPARE MICROPARTICLES OF UNIFORM SIZE [J].
MURAMATSU, N ;
KONDO, T .
JOURNAL OF MICROENCAPSULATION, 1995, 12 (02) :129-136
[5]   Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Manufacture and characterization [J].
O'Hara, P ;
Hickey, AJ .
PHARMACEUTICAL RESEARCH, 2000, 17 (08) :955-961
[6]   Preparation of microspheres by the solvent evaporation technique [J].
ODonnell, PB ;
McGinity, JW .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :25-42
[7]  
OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
[8]  
OKADA H, 1994, J CONTROL RELEASE, V28, P121
[9]   SYNTHESIS OF POLYMERIC MICROSPHERES EMPLOYING SPG EMULSIFICATION TECHNIQUE [J].
OMI, S ;
KATAMI, K ;
YAMAMOTO, A ;
ISO, M .
JOURNAL OF APPLIED POLYMER SCIENCE, 1994, 51 (01) :1-11
[10]   Preparation of monodisperse microspheres using the Shirasu porous glass emulsification technique [J].
Omi, S .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 1996, 109 :97-107